CMCC

Major milestone for Canadian cannabis company & CMCC member Peace Naturals!

Cronos cracks the Nasdaq, a first for Canadian cannabis Ma*****na producer makes its debut on the U.S. exchange despite nagging doubts among American investors

"Canada is about to take a welcome step towards the regulation and taxation of adult recreational use of cannabis, but this shouldn’t come at the expense of the hundreds of thousands of critically and chronically ill Canadians who currently benefit from the use of medical cannabis."

CMCC Looks Forward to Consultation on New Cannabis Regulations The Canadian Medical Cannabis (CMCC) was pleased to see the federal government release an ambitious set of regulatory recommendations concerning both recreational and medical cannabis in Canada, and we look forward to the opportunity to consult with the government on this important issue in the comi

Philippe Lucas, CMCC executive director, joined a panel discussion on policies in Canada hosted by Public Affairs Association of Canada today.

"We strongly oppose extending the proposed 10% excise tax on recreational cannabis to medical cannabis, thereby increasing the cost to critically and chronically ill Canadians who benefit from its use, many of whom are on fixed income and already struggling to cover the cost of medical cannabis."

Statement on Canadian government's proposed excise tax on medical cannabis Today, the Canadian Medical Cannabis Council released a statement on the Canadian government's proposed 10% excise tax on medical cannabis.

Today, the Coalition for Responsible Cannabis Branding released the Adult Use Cannabis Advertising and Marketing Guidelines for Licensed Producers. The proposed guidelines, which if endorsed by government, would come into effect following the legalization of adult consumer use of cannabis in July 2018, are designed to protect youth and the safety of all Canadians, while also ensuring that Licensed Producers can compete effectively with Canada's thriving illicit market.

Canada's Leading Licensed Producers Release Recommendations for Responsible Cannabis Branding & Marketing Guidelines

"The law as proposed would criminalize Canadians who use medical cannabis responsibly – even when they are not actually impaired."

Zaid, Valleriani and Thurley: Impaired driving bill overly targets medical cannabis users Recently, the House of Commons Standing Committee on Justice and Human Rights has focused its attention on Bill C-46, which will tighten impaired driving laws, particularly cannabis impaired drivin…

Today, Philippe Lucas, CMCC’s executive director and Tilray's vice-president of patient access and research, met with the House of Commons Health Committee as part of its full-day hearings on Bill C-45, the federal government’s legalization of cannabis for recreational use. Lucas urged the committee to remove taxes on medical cannabis, shared data on the substitution of cannabis for opioids and alcohol, and suggested responsible branding directed at adults would maximize the benefit of legalization by helping to differentiate between legal and illegal supply.

Acceptance of medical cannabis took another step forward with the announcement of WorkSafeNB’s stakeholder consultation on a new policy on using ma*****na for medical purposes. While the policy is conservative (allowing only products rich in CBD), we’d like to congratulate WorkSafeNB on providing patients with another safe option in health care.

www.worksafenb.ca

A coalition of leading Canadian academics and researchers is calling on federal policymakers to ensure cannabis research and evaluation are prioritized in order to guide health policy related to the federal government’s plans to legalize and regulate the adult use of cannabis.

Evaluation of legal cannabis must be prioritized to protect public health: Researchers Leading Canadian researchers call on federal government to prioritize research to maximize benefits and mitigate harms of legal cannabis Vancouver, BC [June 19, 2017]—A coalition of leading Canadian academics and researchers is calling on federal policymakers to ensure cannabis research and evalu

Study shows lower rates of and among patients who supplement or replace treatment with medical :

Medical cannabis may not only ease suffering, but also save lives. Lower rates of depression and anxiety among patients who supplement or replace treatment with medical cannabis.

Learn about the Canadian Medical Council, our member LPs and Patient Advisory Committee at the Lift Expo this weekend! Stop by for medical accessories.

Congratulations to The Peace Naturals Project on receiving their certificate for Good Manufacturing Practices!

Peace Naturals Awarded GMP Certification Fortifying Global Distribution - The Peace Naturals Project – Cronos Group Inc. (TSXV:MJN) (“Cronos” or the “Company”) is pleased to announce that following a comprehensive audit, the Company’s wholly owned licensed producer (“LP”), the Peace Naturals Project Inc. (“Peace”), has been issued a Good Manufacturing Practice (“GMP”) certification in accordance wi...